The FDA’s planned drug ad rule threatens a dangerous precedent: Make truthful advertising so expensive that companies stop altogether. Burying drug ads in mandatory disclosures could give future administrations a blueprint to target any industry they dislike. Regulators shouldn’t be able to price lawful speech out of existence.

.@nytimes makes itself party to a political hit job on a senator who’s consistently fought to protect patients, improve healthcare price transparency, and lower costs. Unlike hospitals, many of which avoid taxes and have access to federal government grants and other reimbursement schemes when they treat uninsured/underinsured patients, private practice doctors are on their own when patients don’t pay.

When rural OB-GYNs can't get paid by their patients, they go out of business and communities lose access to vital healthcare. That seems to matter less to @nytimes than getting clicks for disparaging a Republican who served his community his entire adult life.

NEW: Empowering bureaucrats to curtail corporate speech and limit access to medical information gives unelected officials veto power over what information Americans are allowed to hear. That’s a dangerous precedent. Patients deserve transparency, access to information and the freedom to make their own healthcare decisions.

Socialist calls for “Medicare for All” neglect the reality of socialized medicine. In the UK, thousands of patients were receiving “corridor care,” treatments in the hallways due to massive overcrowding. In Canada, the median wait time for specialist treatment exceeded 28 weeks.

A new study from @TomasPhilipson examined the first two years of the IRA’s Drug Price Negotiation Program, finding that it will increase the long-term cost of negotiated medicines. Price controls reduce the incentive for generic competitors to enter the market, ultimately raising costs for patients.

We’ve entered the golden age of American medical innovation: sickle-cell disease, cystic fibrosis, and hepatitis C — all curable. Yet patients lack access. The solution isn’t single-payer; it’s smarter deals: guarantee the market, price by region, and reward volume over margin.

Hospital consolidation is making health care more expensive. A knee replacement at Catawba Valley Medical Center costs about $16,000. At Mission Hospital, just over an hour away, the same procedure under the same insurance plan costs around $40,000.

Why? Mission was formed by merging the region’s two largest hospitals, leaving patients with less competition and giving the system more power to demand higher prices. Patients deserve competition, transparency, and the power to decide where their health care dollars go.

The Trump administration is taking aim at one of the biggest drivers of high drug costs: the slow, expensive FDA approval process. Operation Trialblazer will bring treatments to patients faster, increase competition, and lower costs without relying on government price controls.